An estimated 15% of patients in the cath lab are nonrevascularizable. Dr Bernard Gersh talks to Dr Amir Lerman about the therapeutic options for these people, how we define optimal medical therapy in this patient set, and what solutions the future might hold.

#8: Options for the nonrevascularizable patient with Dr Amir Lerman

Mayo Clinic in collaboration with theheart.org brings you context to the latest news, trials, and trends in cardiovascular medicine.<br />
.<img width="600" height="600" alt="" border="0" src="http://media.theheart.org/podcasts/Mayo_Clinic/Photo/itunes-album_covers-Mayo-600.jpg">

Medicine

Mayo Clinic in collaboration with theheart.org brings you context to the latest news, trials, and trends in cardiovascular medicine. .

Mayo Clinic in collaboration with theheart.org brings you context to the latest news, trials, and trends in cardiovascular medicine.<br>
.

Share #8: Options for the nonrevascularizable patient with Dr Amir Lerman

Sign up to save your podcasts

#8: Options for the nonrevascularizable patient with Dr Amir Lerman

#8: Options for the nonrevascularizable patient with Dr Amir Lerman

More shows like Mayo Clinic Talks

Discussions about Cardiology from theheart.org

Fellows’ corner on theheart.org

L’interview minute en cardiologie

Trials and PIs with Dr Michael Gibson

Rendez-vous éditoriaux

Life and Times

Digital Man

Cardiology in India